Taking steps to revive domestic market growth: Dr Reddy's
Satish Reddy, VC & MD at Dr Reddy's Lab, believes that bio-similar portfolio has tremendous potential in the industry. He further adds that the company is looking to build-up a major injectibles portfolio.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
